M P Galloway

424 total citations
9 papers, 373 citations indexed

About

M P Galloway is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, M P Galloway has authored 9 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 4 papers in Psychiatry and Mental health and 2 papers in Molecular Biology. Recurrent topics in M P Galloway's work include Neurotransmitter Receptor Influence on Behavior (4 papers), Attention Deficit Hyperactivity Disorder (3 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). M P Galloway is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (4 papers), Attention Deficit Hyperactivity Disorder (3 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). M P Galloway collaborates with scholars based in United States. M P Galloway's co-authors include Susan Benloucif, T. C. Westfall, R.H. Roth, Richard Berchou, Peter A. LeWitt, John F. Reinhard, Dennis Deptula, Richard J. Brooderson, Nunzio Pomara and Francis J. White and has published in prestigious journals such as Circulation Research, American Journal of Psychiatry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

M P Galloway

9 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M P Galloway United States	9	268	151	84	62	35	9	373
Hans Kvande Sweden	10	218 0.8×	83 0.5×	110 1.3×	34 0.5×	36 1.0×	13	397
Maria Grabowska‐Andén Sweden	12	420 1.6×	256 1.7×	82 1.0×	42 0.7×	41 1.2×	20	548
A S Freeman United States	9	316 1.2×	165 1.1×	43 0.5×	47 0.8×	60 1.7×	15	380
Lloyd Kg France	9	313 1.2×	147 1.0×	53 0.6×	62 1.0×	39 1.1×	20	418
G.U. Corsini Italy	9	187 0.7×	91 0.6×	94 1.1×	43 0.7×	36 1.0×	20	374
N.S. Doggett United Kingdom	12	312 1.2×	176 1.2×	53 0.6×	49 0.8×	39 1.1×	36	459
Tabasum Hussain Australia	6	201 0.8×	120 0.8×	46 0.5×	102 1.6×	49 1.4×	7	336
Barton G. Weick United States	11	322 1.2×	153 1.0×	139 1.7×	25 0.4×	26 0.7×	16	470
J.P. Lhuintre France	8	402 1.5×	142 0.9×	147 1.8×	54 0.9×	46 1.3×	9	583
Andreas E. Theodorou United Kingdom	12	224 0.8×	124 0.8×	39 0.5×	132 2.1×	40 1.1×	14	407

Countries citing papers authored by M P Galloway

Since Specialization

Citations

This map shows the geographic impact of M P Galloway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M P Galloway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M P Galloway more than expected).

Fields of papers citing papers by M P Galloway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M P Galloway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M P Galloway. The network helps show where M P Galloway may publish in the future.

Co-authorship network of co-authors of M P Galloway

This figure shows the co-authorship network connecting the top 25 collaborators of M P Galloway. A scholar is included among the top collaborators of M P Galloway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M P Galloway. M P Galloway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Benloucif, Susan, et al.. (1993). Serotonin-facilitated dopamine release in vivo: pharmacological characterization.. Journal of Pharmacology and Experimental Therapeutics. 265(1). 373–377. 194 indexed citations

Galloway, M P, et al.. (1992). Acute administration of amphetamine: differential regulation of dopamine synthesis in dopamine projection fields.. Journal of Pharmacology and Experimental Therapeutics. 261(2). 567–573. 15 indexed citations

Brooderson, Richard J., Francis J. White, & M P Galloway. (1990). Inhibition of dopamine synthesis in striatal slices by the D1 agonist SKF 38393 is not mediated by D1 dopamine receptors. Synapse. 6(4). 395–397. 8 indexed citations

Berchou, Richard, et al.. (1989). Controlled-release carbidopa/levodopa (Sinemet 50/200 CR4): clinical and pharmacokinetic studies.. PubMed. 39(11 Suppl 2). 45–53; discussion 59. 42 indexed citations

Berchou, Richard, et al.. (1989). Pharmacokinetic and Pharmacodynamic Modeling of L-DOPA Plasma Concentrations and Clinical Effects in Parkinsonʼs Disease After Sinemet. Clinical Neuropharmacology. 12(2). 91–97. 19 indexed citations

Pomara, Nunzio, et al.. (1989). CSF GABA in caregiver spouses of Alzheimer patients. American Journal of Psychiatry. 146(6). 787–788. 14 indexed citations

Galloway, M P & R.H. Roth. (1983). Neuropharmacology of 3-isobutylmethylxanthine: effects on central noradrenergic systems in vivo.. Journal of Pharmacology and Experimental Therapeutics. 227(1). 1–8. 22 indexed citations

Reinhard, John F., M P Galloway, & R.H. Roth. (1983). Noradrenergic modulation of serotonin synthesis and metabolism. II. Stimulation by 3-isobutyl-1-methylxanthine.. Journal of Pharmacology and Experimental Therapeutics. 226(3). 764–769. 17 indexed citations

Galloway, M P & T. C. Westfall. (1982). The release of endogenous norepinephrine from the coccygeal artery of spontaneously hypertensive and Wistar-Kyoto rats.. Circulation Research. 51(2). 225–232. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact